PURPOSE OF REVIEW: The purpose of this study is to review advances in both the pathogenesis and clinical management of biliary atresia. RECENT FINDINGS: Immunologic studies have further characterized roles of helper T-cells, B-cells, and natural killer cells in the immune dysregulation following viral replication within and damage of biliary epithelium. Prominin-1-expressing portal fibroblasts may play an integral role in the biliary fibrosis associated with biliary atresia. A number of genetic polymorphisms have been characterized as leading to susceptibility for biliary atresia. Postoperative corticosteroid therapy is not associated with greater transplant-free survival. Newborn screening may improve outcomes of infants with biliary atresia and may also provide a long-term cost benefit. SUMMARY: Although recent advances have enhanced our understanding of pathogenesis and clinical management, biliary atresia remains a significant challenge requiring further investigation.
PURPOSE OF REVIEW: The purpose of this study is to review advances in both the pathogenesis and clinical management of biliary atresia. RECENT FINDINGS: Immunologic studies have further characterized roles of helper T-cells, B-cells, and natural killer cells in the immune dysregulation following viral replication within and damage of biliary epithelium. Prominin-1-expressing portal fibroblasts may play an integral role in the biliary fibrosis associated with biliary atresia. A number of genetic polymorphisms have been characterized as leading to susceptibility for biliary atresia. Postoperative corticosteroid therapy is not associated with greater transplant-free survival. Newborn screening may improve outcomes of infants with biliary atresia and may also provide a long-term cost benefit. SUMMARY: Although recent advances have enhanced our understanding of pathogenesis and clinical management, biliary atresia remains a significant challenge requiring further investigation.
Authors: Mark Davenport; Mark D Stringer; Sarah A Tizzard; Patricia McClean; Giorgina Mieli-Vergani; Nedim Hadzic Journal: Hepatology Date: 2007-12 Impact factor: 17.425
Authors: Benjamin L Shneider; Morton B Brown; Barbara Haber; Peter F Whitington; Kathleen Schwarz; Robert Squires; Jorge Bezerra; Ross Shepherd; Philip Rosenthal; Jay H Hoofnagle; Ronald J Sokol Journal: J Pediatr Date: 2006-04 Impact factor: 4.406
Authors: Mark Davenport; J De Ville de Goyet; M D Stringer; G Mieli-Vergani; D A Kelly; P McClean; L Spitz Journal: Lancet Date: 2004-04-24 Impact factor: 79.321
Authors: Richard A Schreiber; Lisa Masucci; Janusz Kaczorowski; J P Collet; Pamela Lutley; Victor Espinosa; Stirling Bryan Journal: J Med Screen Date: 2014-07-09 Impact factor: 2.136
Authors: Li Yang; Pranavkumar Shivakumar; Jeremy Kinder; Sing Sing Way; Bryan Donnelly; Reena Mourya; Zhenhua Luo; Jorge A Bezerra Journal: JCI Insight Date: 2020-06-04
Authors: Marie V Nguyen; Jessica A Zagory; William H Dietz; Alex Park; Michael Fenlon; Menghan Zhao; Jiabo Xu; Ingrid Lua; Nirmala Mavila; Kinji Asahina; Kasper S Wang Journal: Surgery Date: 2017-01-16 Impact factor: 3.982
Authors: Jessica A Zagory; Michael Fenlon; William Dietz; Menghan Zhao; Marie V Nguyen; Pavin Trinh; Maeva Adoumie; Alex Park; Jiabo Xu; Elaa Mahdi; Alison Glazier; Nicolas Malkoff; Nirmala Mavila; Kasper S Wang Journal: Hepatology Date: 2019-04-11 Impact factor: 17.425